60
Views
6
CrossRef citations to date
0
Altmetric
Device Profile

NaviStar® ThermoCool® catheter for ventricular tachycardia

&
Pages 307-314 | Published online: 09 Jan 2014

References

  • Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation101(11), 1288–1296 (2000).
  • Atiga WL, Worley SJ, Hummel J et al. Prospective randomized comparison of cooled radiofrequency versus standard radiofrequency energy for ablation of typical atrial flutter. Pacing Clin. Electrophysiol.25(8), 1172–1178 (2002).
  • Calkins H. Catheter ablation of atrial flutter: do outcomes of catheter ablation with “large-tip” versus “cooled-tip” catheters really differ? J. Cardiovasc. Electrophysiol.15(10), 1131–1132 (2004).
  • Da Costa A, Cucherat M, Pichon N et al. Comparison of the efficacy of cooled-tip and 8-mm-tip catheters for radiofrequency catheter ablation of the cavotricuspid isthmus: a meta-analysis. Pacing Clin. Electrophysiol.28(10), 1081–1087 (2005).
  • Dixit S, Gerstenfeld EP, Callans DJ et al. Comparison of cool tip versus 8-mm tip catheter in achieving electrical isolation of pulmonary veins for long-term control of atrial fibrillation: a prospective randomized pilot study. J. Cardiovasc. Electrophysiol.17(10), 1074–1079 (2006).
  • Horlitz M, Schley P, Shin DI et al. Circumferential pulmonary vein ablation for treatment of atrial fibrillation using an irrigated-tip catheter. Am. J. Cardiol.94(7), 945–947 (2004).
  • Jais P, Shah DC, Haissaguerre M et al. Prospective randomized comparison of irrigated-tip versus conventional-tip catheters for ablation of common flutter. Circulation101(7), 772–776 (2000).
  • Macle L, Jais P, Weerasooriya R et al. Irrigated-tip catheter ablation of pulmonary veins for treatment of atrial fibrillation. J. Cardiovasc. Electrophysiol.13(11), 1067–1073 (2002).
  • Marrouche NF, Dresing T, Cole C et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. J. Am. Coll. Cardiol.40(3), 464–474 (2002).
  • Thomas SP, Aggarwal G, Boyd AC, Jin Y, Ross DL. A comparison of open irrigated and non-irrigated tip catheter ablation for pulmonary vein isolation. Europace6(4), 330–335 (2004).
  • Haines D. Biophysics of ablation: application to technology. J. Cardiovasc. Electrophysiol.15(10 Suppl.), S2–S11 (2004).
  • Simmers TA, de Bakker JM, Coronel R et al. Effects of intracavitary blood flow and electrode-target distance on radiofrequency power required for transient conduction block in a Langendorff-perfused canine model. J. Am. Coll. Cardiol.31(1), 231–235 (1998).
  • Haines DE, Verow AF. Observations on electrode-tissue interface temperature and effect on electrical impedance during radiofrequency ablation of ventricular myocardium. Circulation82(3), 1034–1038 (1990).
  • Petersen HH, Chen X, Pietersen A, Svendsen JH, Haunso S. Temperature-controlled radiofrequency ablation of cardiac tissue: an in vitro study of the impact of electrode orientation, electrode tissue contact pressure and external convective cooling. J. Interv. Card. Electrophysiol.3(3), 257–262 (1999).
  • Nakagawa H, Wittkampf FH, Yamanashi WS et al. Inverse relationship between electrode size and lesion size during radiofrequency ablation with active electrode cooling. Circulation98(5), 458–465 (1998).
  • Chan RC, Johnson SB, Seward JB, Packer DL. The effect of ablation electrode length and catheter tip to endocardial orientation on radiofrequency lesion size in the canine right atrium. Pacing Clin. Electrophysiol.25(1), 4–13 (2002).
  • Haines DE, Watson DD, Verow AF. Electrode radius predicts lesion radius during radiofrequency energy heating. Validation of a proposed thermodynamic model. Circ. Res.67(1), 124–129 (1990).
  • Otomo K, Yamanashi WS, Tondo C et al. Why a large tip electrode makes a deeper radiofrequency lesion: effects of increase in electrode cooling and electrode-tissue interface area. J. Cardiovasc. Electrophysiol.9(1), 47–54 (1998).
  • Matsumoto N, Kishi R, Kasugai H et al. Experimental study on the effectiveness and safety of radiofrequency catheter ablation with the cooled ablation system. Circ. J.67(2), 154–158 (2003).
  • Ruffy R, Imran MA, Santel DJ, Wharton JM. Radiofrequency delivery through a cooled catheter tip allows the creation of larger endomyocardial lesions in the ovine heart. J. Cardiovasc. Electrophysiol.6(12), 1089–1096 (1995).
  • Nakagawa H, Yamanashi WS, Pitha JV et al. Comparison of in vivo tissue temperature profile and lesion geometry for radiofrequency ablation with a saline-irrigated electrode versus temperature control in a canine thigh muscle preparation. Circulation91(8), 2264–2273 (1995).
  • Cooper JM, Sapp JL, Tedrow U et al. Ablation with an internally irrigated radiofrequency catheter: learning how to avoid steam pops. Heart Rhythm1(3), 329–333 (2004).
  • Bruce GK, Bunch TJ, Milton MA, Sarabanda A, Johnson SB, Packer DL. Discrepancies between catheter tip and tissue temperature in cooled-tip ablation: relevance to guiding left atrial ablation. Circulation112(7), 954–960 (2005).
  • Weiss C, Antz M, Eick O, Eshagzaiy K, Meinertz T, Willems S. Radiofrequency catheter ablation using cooled electrodes: impact of irrigation flow rate and catheter contact pressure on lesion dimensions. Pacing Clin. Electrophysiol.25(4 Pt 1), 463–469 (2002).
  • Dorwarth U, Fiek M, Remp T et al. Radiofrequency catheter ablation: different cooled and noncooled electrode systems induce specific lesion geometries and adverse effects profiles. Pacing Clin. Electrophysiol.26(7 Pt 1), 1438–1445 (2003).
  • Yokoyama K, Nakagawa H, Wittkampf FH, Pitha JV, Lazzara R, Jackman WM. Comparison of electrode cooling between internal and open irrigation in radiofrequency ablation lesion depth and incidence of thrombus and steam pop. Circulation113(1), 11–19 (2006).
  • Anh DJ, Hsia HH, Reitz B, Zei P. Epicardial ablation of post-infarction ventricular tachycardia with an externally irrigated catheter in a patient with mechanical aortic and mitral valves. Heart Rhythm DOI: 10.1016/j.hrthm.2007.01.011 (2007) (Epub ahead of print).
  • Yamane T, Jais P, Shah DC et al. Efficacy and safety of an irrigated-tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation. Circulation102(21), 2565–2568 (2000).
  • Scheinman MM. NASPE survey on catheter ablation. Pacing Clin. Electrophysiol.18(8), 1474–1478 (1995).
  • Calkins H. Cooled ablation. J. Cardiovasc. Electrophysiol.15(10 Suppl.), S12–S17 (2004).
  • Gursoy S, Chiladakis I, Kuck KH. First lessons from radiofrequency catheter ablation in patients with ventricular tachycardia. Pacing Clin. Electrophysiol.16(3 Pt 2), 687–691 (1993).
  • Morady F, Harvey M, Kalbfleisch SJ, el-Atassi R, Calkins H, Langberg JJ. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation87(2), 363–372 (1993).
  • Stevenson WG, Khan H, Sager P et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation88(4 Pt 1), 1647–1670 (1993).
  • Kim YH, Sosa-Suarez G, Trouton TG et al. Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. Circulation89(3), 1094–1102 (1994).
  • Gonska BD, Cao K, Schaumann A, Dorszewski A, von zur Muhlen F, Kreuzer H. Catheter ablation of ventricular tachycardia in 136 patients with coronary artery disease: results and long-term follow-up. J. Am. Coll. Cardiol.24(6), 1506–1514 (1994).
  • Cao K, Gonska BD. Catheter ablation of incessant ventricular tachycardia: acute and long-term results. Eur. Heart J.17(5), 756–763 (1996).
  • Rothman SA, Hsia HH, Cossu SF, Chmielewski IL, Buxton AE, Miller JM. Radiofrequency catheter ablation of postinfarction ventricular tachycardia: long-term success and the significance of inducible nonclinical arrhythmias. Circulation96(10), 3499–3508 (1997).
  • Strickberger SA, Man KC, Daoud EG et al. A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator. Circulation96(5), 1525–1531 (1997).
  • Stevenson WG, Friedman PL, Kocovic D, Sager PT, Saxon LA, Pavri B. Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation98(4), 308–314 (1998).
  • Calkins H, Epstein A, Packer D et al. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multi Center Investigators Group. J. Am. Coll. Cardiol.35(7), 1905–1914 (2000).
  • Nabar A, Rodriguez LM, Timmermans C, Wellens HJ. Use of a saline-irrigated tip catheter for ablation of ventricular tachycardia resistant to conventional radiofrequency ablation: early experience. J. Cardiovasc. Electrophysiol.12(2), 153–161 (2001).
  • Soejima K, Delacretaz E, Suzuki M et al. Saline-cooled versus standard radiofrequency catheter ablation for infarct-related ventricular tachycardias. Circulation103(14), 1858–1862 (2001).
  • Reddy VY, Neuzil P, Taborsky M, Ruskin JN. Short-term results of substrate mapping and radiofrequency ablation of ischemic ventricular tachycardia using a saline-irrigated catheter. J. Am. Coll. Cardiol.41(12), 2228–2236 (2003).
  • FDA CDRH. Navistar™ ThermoCool® deflectable diagnostic/ablation catheter – P040036 Labeling.
  • Kaltenbrunner W, Cardinal R, Dubuc M et al. Epicardial and endocardial mapping of ventricular tachycardia in patients with myocardial infarction. Is the origin of the tachycardia always subendocardially localized? Circulation84(3), 1058–1071 (1991).
  • Volkmer M, Ouyang F, Deger F et al. Substrate mapping vs. tachycardia mapping using CARTO in patients with coronary artery disease and ventricular tachycardia: impact on outcome of catheter ablation. Europace8(11), 968–976 (2006).
  • Verma A, Marrouche NF, Schweikert RA et al. Relationship between successful ablation sites and the scar border zone defined by substrate mapping for ventricular tachycardia post-myocardial infarction. J. Cardiovasc. Electrophysiol.16(5), 465–471 (2005).
  • Arenal A, Glez-Torrecilla E, Ortiz M et al. Ablation of electrograms with an isolated, delayed component as treatment of unmappable monomorphic ventricular tachycardias in patients with structural heart disease. J. Am. Coll. Cardiol.41(1), 81–92 (2003).
  • Khongphatthanayothin A, Kosar E, Nademanee K. Nonfluoroscopic three-dimensional mapping for arrhythmia ablation: tool or toy? J. Cardiovasc. Electrophysiol.11(3), 239–243 (2000).
  • Mason JW. The electrophysiologic study versus electrocardiographic monitoring I. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N. Engl. J. Med.329(7), 452–458 (1993).
  • Connolly SJ, Dorian P, Roberts RS et al. Comparison of β-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA295(2), 165–171 (2006).
  • Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation110(2), 112–116 (2004).
  • No authors listed. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N. Engl. J. Med.337(22), 1576–1583 (1997).
  • Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. J. Am. Coll. Cardiol.32(7), 1909–1915 (1998).
  • Villacastin J, Almendral J, Arenal A et al. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators. Circulation93(4), 753–762 (1996).
  • Sadoul N, Mletzko R, Anselme F et al. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Circulation112(7), 946–953 (2005).
  • Sweeney MO, Wathen MS, Volosin K et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation111(22), 2898–2905 (2005).
  • Gradaus R, Block M, Brachmann J et al. Mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results from the German ICD Registry EURID. Pacing Clin. Electrophysiol.26(7 Pt 1), 1511–1518 (2003).
  • Irvine J, Dorian P, Baker B et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am. Heart J.144(2), 282–289 (2002).
  • Bilge AK, Ozben B, Demircan S, Cinar M, Yilmaz E, Adalet K. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin. Electrophysiol.29(6), 619–626 (2006).
  • Eckardt L, Breithardt G. Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator? Heart Rhythm3(4), 484–487 (2006).
  • Khan HH, Maisel WH, Ho C et al. Effect of radiofrequency catheter ablation of ventricular tachycardia on left ventricular function in patients with prior myocardial infarction. J. Interv. Card. Electrophysiol.7(3), 243–247 (2002).
  • Al-Rawahi N, Davis DR, Birnie DH et al. The use of a novel magnetic navigation system for remote catheter ablation of ischemic ventricular tachycardia. Can. J. Cardiol.22(Suppl. D), 58D (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.